INTRODUCTION
The Myc family of transcription factors comprises c-Myc, N-Myc, and L-Myc and has been implicated in the generation of a variety of human tumors. Enhanced Myc expression has been shown to contribute to several aspects of tumorigenesis (Adhikary and Eilers, 2005) including unrestricted proliferation (Eilers et al., 1991) , inhibition of differentiation (Freytag and Geddes, 1992) , cell growth and metabolism (Dang, 2013; Iritani and Eisenman, 1999; Johnston et al., 1999) , reduction of cell adhesion (Arnold and Watt, 2001) , and metastasis (Pelengaris et al., 2002) . The role of Myc proteins in development has been widely investigated making use of gene targeting in mice: whereas L-myc knockout mice develop normally (Hatton et al., 1996) , embryos lacking c-myc die before E10.5 due to hematopoietic and placental defects (Dubois et al., 2008; Trumpp et al., 2001) , and N-myc-deficient embryos die before E11.5 displaying neuroectodermal and heart defects (Charron et al., 1992) . Myc activity is essential for efficient cellular reprogramming (Wernig et al., 2008) and has complex roles in various stem and progenitor cell types ). In the adult hematopoietic system, c-Myc controls the balance between hematopoietic stem cell (HSC) self-renewal and differentiation by regulating the interaction between HSCs and their niche (Wilson et al., 2004) . Interestingly, only the highly quiescent, dormant HSCs survive the simultaneous deletion of both c-myc and N-myc in the hematopoietic system, while all the other hematopoietic cells are rapidly lost due to impaired proliferation, differentiation, and overt apoptosis ). In ESCs grown in serum plus LIF (hereafter referred to as serum), Myc proteins have been suggested to sustain pluripotency by repressing the primitive endoderm master regulator Gata6 and to contribute to cell-cycle control by regulating the mir-17-92 miRNA cluster Varlakhanova et al., 2010) . However, ESCs cultured in serum exhibit heterogeneous expression of pluripotency markers, and only a fraction of these cells correlate with the pre-implantation epiblast, as shown by transcriptional profiling (Boroviak et al., 2014; Marks et al., 2012; Ying et al., 2008) . In contrast, ESCs cultured in 2i plus LIF (hereafter referred to as 2i) are captured in a naive ground state of pluripotency and retain the essential features of the pluripotent epiblast cells (Boroviak et al., 2014 ). The precise function of Myc in naive groundstate ESCs and the role of Myc in the mouse epiblast remain elusive. Here, we use a combination of genetic, transcriptomic, and cellular analyses to show that Myc activity reversibly controls the biosynthetic and proliferative machineries of groundstate naive ESCs without affecting pluripotency and link these data on ESCs to the physiological status of dormant, diapaused embryos.
RESULTS

Myc Is Essential for Proliferation but Not for
Maintenance of the Core Pluripotency Network in Ground-State ESCs Mouse ESCs cultured in serum express significantly higher levels of c-myc and N-myc transcripts compared to ESCs grown in 2i ( Figure 1A ) (Marks et al., 2012) . In agreement with this observation, a lower expression of c-Myc protein in 2i compared to serum was observed by flow cytometry using a c-Myc eGFP knockin allele ( Figure 1B ) (Huang et al., 2008) . Lower expression of c-MYC transcripts was also observed in human H9 ESCs that were reset to a naive state of pluripotency compared to their primed counterparts ( Figure 1C ) (Takashima et al., 2014) . To genetically explore the function of Myc in naive ground-state ESCs, we derived ESC lines from mice homozygous for the c-myc and N-myc floxed alleles (c-myc fl/fl ; N-myc fl/fl ) (Knoepfler et al., 2002; Trumpp et al., 2001 ) as well as the Cre reporter gene Rosa26 lox-stop-loxEYFP (Srinivas et al., 2001 ). All generated ESC lines had the capacity to differentiate into tissues derived from all three germ layers both in vitro and in vivo (Figures S1A and S1B Figure 1D ). We confirmed dKO ESCs in the Cre + population 24 and 96 hr after transfection using both PCR and qRT-PCR analysis (Figures S1H and S1I). FACS analysis of the cell cycle showed that single deletion of either c-myc or N-myc did not affect the proliferative status of naive groundstate ESCs ( Figure S1J ). In contrast, 96 hr after Cre induction dKO ESCs ceased to proliferate and formed very small, domeshaped colonies ( Figure 1E ). This was associated with the complete absence of DNA synthesis ( Figures 1F and 1G) , an increase in G 0 arrested cells ( Figure 1H ), and a fraction of dKO ESCs undergoing apoptosis ( Figures 1I, 1J , and S1K). These data demonstrate that, even in 2i conditions, low levels of c-Myc or N-Myc are required to prevent cell-cycle arrest of ground-state ESCs. Next, we addressed whether Myc-mediated cell-cycle arrest influences pluripotency and lineage differentiation. In 2i, both single KO and dKO ESCs expressed alkaline phosphatase ( Figure 1K ) and unexpectedly also displayed similar levels of Nanog, Oct4, and Sox2 (Figures 1L and S1L-S1M). These data provide evidence that c/N-Myc activity is specifically required for proliferation but dispensable for the expression of the core pluripotency factors in naive ground-state ESCs.
Loss of Myc in Ground-State ESCs Leads to Biosynthetic Quiescence
To further explore the consequences of c/N-myc deletion, we sequenced the transcriptome of ESCs 24 and 96 hr after Cre induction (Figures 2A and S2A ; Table S1; Data S1). As expected, c-myc and N-myc downregulation was confirmed at both time points in the transcriptome data ( Figure S2B ). In line with the immunohistochemistry observations ( Figure 1L ), the transcript levels of the core and extended pluripotency networks (e.g., (E) Phase-contrast microscopy images showing the typical morphology of dKO ESCs. Scale bar, 100 mm. (Marks et al., 2012) . Lineage-specific differentiation genes (germline, ectoderm, endoderm, and mesoderm) were mostly not upregulated ( Figure 2B ), demonstrating that arrested dKO ground-state ESCs maintain expression of the pluripotency network without upregulation of differentiation signatures. To identify genes and processes regulated upon c/N-myc deletion, we classified each gene based on its relative expression pattern in the different conditions with respect to its mean expression level across conditions ( Figure S2D ). Consistent with a function of Myc as both a transcriptional activator and repressor (Adhikary and Eilers, 2005; Walz et al., 2014) , we found 215 genes significantly downregulated (clusters 44 + 48 + 60) and 165 genes upregulated (clusters 5 + 17 + 21) in dKO ESCs (false discovery rate [FDR] = 0.1; Table S2 ). Genes downregulated upon loss of Myc were enriched in Gene Ontology (GO) categories related to several metabolic and biosynthetic aspects of cellular physiology (clusters 44 and 48) including biosynthesis (ribosome biogenesis; e.g., Ipo4, Utp15), gene expression (e.g., Eif3a, Gabp1), metabolism (RNA metabolic process; e.g., Polr1b, Polr3g), nucleus (nuclear part; e.g., Ncl, Xpot), and proliferation (DNA replication; e.g., Orc1, Rfc1) ( Figure 2C ). Translation factors, transcription initiation, and DNA replication were also downregulated in dKO compared to c-myc
To functionally assess the reduction in protein synthesis caused by loss of Myc activity, we made use of an alkyne analog of puromycin, O-propargyl-puromycin (OP-Puro) (Liu et al., 2012; Signer et al., 2014) , that can diffuse through the plasma membrane of living cells, enter the ribosome acceptor sites and be incorporated into the C terminus of nascent polypeptide chains. OP-Puro can be fluorescently labeled with an azide-alkyne reaction, thereby allowing quantification of de novo protein synthesis. By using this assay, we show that OP-Puro incorporation is homogeneously decreased in dKO ESCs 96 hr after Cre induction, confirming the dramatic reduction of protein translation observed in the molecular signature (Figures 2E and S2E) . Consistent with our cell-cycle analysis (Figures 1F and 1H), we found 24 genes related to proliferation to be differentially expressed in dKO ESCs (FDR = 0.1; Figure 2F ). These include Pola1, the regulatory subunit of DNA polymerase, E2f3, known to be critical for normal cellular proliferation (Humbert et al., 2000) and Skp2, among others. Finally, processes related to immune response (positive regulation of immune system process; e.g., Cd74, Fcer1g), development (central nervous system development; e.g., Hes1, Hoxb1) and motility (locomotion; e.g., Klf7, Ndn) were over-represented among the genes upregulated in the dKO ESCs (cluster 17; Figure 2G ). In agreement with previous studies in both HSCs and skin epidermis (Gebhardt et al., 2006; Wilson et al., 2004) , integrin-mediated signaling processes were upregulated in dKO ESCs ( Figure 2D ). Pathways associated with survival and maintenance of ESCs such as IL-6 signaling (Nichols et al., 1994) were enriched in Myc-deficient ESCs ( Figure 2D ). Together, these data indicate that dKO ESCs display an increase in cell adhesion and processes associated with maintenance and survival and enter a state of biosynthetic quiescence, characterized by a strong reduction of protein and nucleic acid synthesis.
The Dormant State Induced by Myc Depletion Is Reversible
Maintenance of pluripotency in the absence of differentiation raised the question whether the proliferative and biosynthetic quiescence observed in the dKO ESCs represents a terminal or a reversible status. To approach this, we transfected dKO cells with synthetic c-myc mRNAs to transiently restore Myc activity ( Figure 3A ) (Warren et al., 2010) . Upon expression of exogenous c-myc mRNAs, dKO ESCs re-entered the cell cycle, as shown by a significant increase in 5-bromo-2 0 -deoxyuridine (BrdU) incorporation ( Figure 3B ) and restoration of translational activity ( Figures 3C and S3A ). These results indicate that upon re-expression of c-myc by exogenous mRNAs, dKO ESCs transiently exit the status of biosynthetic dormancy and restore protein biosynthesis and DNA replication. The dimerization of Myc with Max, a helix-loop-helix leucine zipper protein, is necessary for the binding of Myc to the promoters of its target genes (Blackwood and Eisenman, 1991; Eilers and Eisenman, 2008) . Lowmolecular-weight compounds, such as 10058-F4, have been shown to inhibit both c-Myc and N-Myc activity by selective targeting of Myc-Max dimerization both in vitro and in vivo (Rahl et al., 2010; Zirath et al., 2013) . In order to evaluate the longterm reversibility of the phenotype induced by Myc depletion, we treated naive ground-state ESCs with the Myc inhibitor 10058-F4 (MYCi) for 60 hr and analyzed the effect on cell proliferation, protein translation, and pluripotency. Entirely consistent with our previous results on dKO cells, mouse ESCs cultured in the presence of MYCi formed small, undifferentiated colonies ( Figure 3D ), which showed drastically reduced DNA and protein synthesis ( Figures 3E, 3F , S3B, and S3C) but retained the expression of pluripotency factors such as Nanog and Oct4 (Figures 3G and S3D) . Importantly, upon withdrawal of the inhibitor, these ''released'' cells (MYCi / released) rapidly exited the state of dormancy and reactivated both DNA and protein synthesis ( Figures 3E, 3F , S3B, and S3C). We next compared the microarray expression profiles of ESCs cultured for 60 hr with the MYCi to the ones of control cells (control) or inhibitor-treated ESCs, 48 hr after MYCi withdrawal (released). This analysis revealed 3,570 differentially expressed genes (DEGs) between MYCi ESCs and the control group (FDR = 0.05, log 2 fold change ± 0.5; Figure 3H ; Table S3 ). Consistent with the GO terms (legend on next page) enriched in the RNA sequencing (RNA-seq) analysis of the dKO cells ( Figures 2C and 2G ), processes related to cellular growth (e.g., mRNA processing; ribosome biogenesis), metabolism (e.g., DNA metabolic process) and proliferation (e.g., cell cycle; DNA replication) were strongly downregulated upon MYCi treatment. In contrast, processes related to signaling (e.g., regulation of signal transduction) and development (e.g., developmental process) were consistently upregulated ( Figure S3E ). Importantly, the comparison of the MYCi-treated with the released group showed rapid re-activation of all the biosynthetic and proliferative activities: genes and GO terms related to mRNA processing (e.g., Polr2d; Srpk1), RNA splicing (e.g., Syncript; Srsf1), ribosome biogenesis (e.g., Ncl; Wdr12), DNA replication (e.g., Cdc6; Dna2), and cell cycle (e.g., Ccnd1) were rapidly upregulated in the released group already 48 hr after withdrawal of the inhibitor ( Figures 3I and 3J ). Interestingly, Cdk6, recently shown to regulate exit from quiescence in human HSCs (Laurenti et al., 2015) , was also rapidly induced upon exit from the Mycinduced dormant state in mouse ESCs ( Figure 3J ). Despite the transient depletion of Myc activity, ESCs retained their functional pluripotency and upon exit from the state of dormancy, MYCi-released ESCs were capable of both in vitro and in vivo differentiation toward the three germ layers ( Figures 3K and  3L ). In summary, our data indicate that treatment of ESCs with MYCi not only recapitulates the dKO phenotype at the molecular and functional level, but also demonstrates that the status of biosynthetic dormancy induced by transient loss of Myc activity in naive ground-state ESCs is reversible and occurs without compromising their stem cell identity and pluripotent potential.
Comparison of Expression Signatures between Myc-Depleted ESCs and the Diapause Epiblast
In numerous invertebrates and almost 100 mammalian species, embryonic development can be reversibly arrested as a strategy to enhance the reproductive fitness in response to changes in the living environment (Renfree and Shaw, 2000) . In breastfeeding mice, delayed implantation, termed diapause, can occur in response to decreased levels of estrogen, which cause blastocysts to enter a transient dormant state of metabolic and proliferative quiescence (Hondo and Stewart, 2005; Mantalenakis and Ketchel, 1966) . Our observation that the combined loss of c-myc and N-myc in ground-state ESCs induces biosynthetic dormancy raised the possibility that dKO ESCs may resemble a state equivalent to mammalian epiblast cells in diapause. To test this hypothesis, we experimentally induced delayed implantation by ovariectomizing E2.5 pregnant females and isolated diapaused embryos 4 days later. Additionally, we made use of recently generated transcriptome profiling data (RNA-seq) of diapaused and E4.5 pre-implantation epiblasts (Table S4 ) (Boroviak et al., 2015) . As expected, diapaused embryos retained an active pluripotency network, as shown by the expression of Nanog, Oct4, and Zfp42 ( Figures 4A-4C ) Silva et al., 2009) . Remarkably, the expression of c-Myc proteins and transcripts was low to undetectable during diapause ( Figures 4D, 4E , S4A, and S4B), and Myc downregulation was associated with a significant decrease of Ki67 expression ( Figures S4C and S4D ) and reduced incorporation of both EdU (5-Ethynyl-2 0 -deoxyuridine) and OP-Puro ( Figures 4F, 4G , S4E, and S4F). This reduction in DNA and protein synthesis functionally describes the state of biosynthetic and proliferative quiescence of diapaused embryos and remarkably resembles the functional phenotype of dKO ESCs. To evaluate the similarity of dKO ESCs to the diapause epiblast, we compared the molecular expression signatures of dKO cells to those of normal preimplantation and diapaused epiblasts (Table S4) (Boroviak et al., 2015) . Performing 2D GO enrichment analysis of RNA expression changes (comparing control ESCs/dKO ESCs and E4.5 normal/diapause epiblasts; Figure 5A ), we found that genes from specific biological processes showed a strong positive correlation between both datasets. Specifically, processes related to gene expression (e.g., RNA processing, RNA splicing, RNA export from nucleus), protein synthesis (e.g., ribosome biogenesis, translation), and proliferation (e.g., DNA replication, replication fork, chromosome segregation) were robustly downregulated in both datasets ( Figures 5B-5D and S5A-S5C). In contrast, processes related to cell adhesion (e.g., Integrin binding) and signaling (e.g., signaling receptor activity, G protein coupled receptor activity) were commonly upregulated ( Figures  5E, S5D , and S5E). These expression profiling data strongly indicate that the transcriptomic changes occurring upon Myc depletion in naive ground-state ESCs closely correlate with the ones observed during induction of diapause.
Inhibition of Myc Activity in Mouse Blastocysts Induces a Diapause-like State of Dormancy
To investigate whether reduction of Myc activity can induce a diapause-like state in normal, pre-implantation embryos, we isolated E3.75-E4.0 blastocysts and cultured them in the presence of the MYCi for 18 hr. This resulted in a striking reduction of both de novo protein synthesis ( Figures 6A and 6B ) and cellular proliferation ( Figure 6C ). Importantly, pluripotency markers such as Oct4 were still expressed upon Myc inhibition ( Figure 6D ), highlighting the maintenance of the stem cell circuitry in the epiblast of Myc-inhibited embryos. Next, we assessed the ability of those Myc-inhibited, diapause-like blastocysts to resume development upon withdrawal of MYCi by transferring MYCi-treated embryos into the uterus of pseudopregnant foster mothers. MYCi-treated blastocysts yielded morphologically normal embryos at E15.5 and live born pups ( Figures 6E and 6F) . These findings not only show that Myc is downregulated in diapause embryos, but also demonstrate that transient reduction of Myc activity is sufficient to drive embryos into a reversible diapause-like state, functionally characterized by strong reduction of proliferation and protein synthesis while a fully functional pluripotent developmental program is maintained.
DISCUSSION
The stem cell self-renewal comprises two biological processes, namely, cellular growth-proliferation linked to inhibition of differentiation. The latter is synonymous with the capacity to maintain stem cell pluripotency or multipotency in at least one of the daughter cells after cell division. By using both a genetic model and an inhibitor of Myc activity, our data demonstrate that, while Myc controls biosynthetic activity and cellular proliferation of naive ground-state ESCs, the maintenance of pluripotency and stem cell identity is independent of Myc. In the absence of Myc activity, maintenance of pluripotency and the associated lack of differentiation are only observed in 2i-cultured groundstate ESCs and in the blastocyst. These findings suggest that the effects of Myc are highly linked to the microenvironmental signals naturally present in the uterus and recapitulated in vitro by the 2i culture. Thus, the two key components of ESC selfrenewal can be separated into a Myc-controlled biosynthetic program and a Myc-independent pluripotency program. These results strongly support findings in other cell types, including cancer cells (Carroll et al., 2015; Dang, 2013 Dang, , 2015 , and are in agreement with a recently described Myc-centered transcriptional module (Kim et al., 2010) . Diapause is a unique biological phenomenon, developed in many invertebrates (e.g., butterflies, C. elegans) and mammals (e.g., rodents, deer) as a reproductive strategy to survive predictable, unfavorable environmental conditions, such as temperature extremes, drought, or reduced food availability (Renfree and Shaw, 2000) . In the mouse, hormonally mediated diapause of pre-implantation embryos occurs if the mother still nurses pups of the previous litter (Hondo and Stewart, 2005; Mantalenakis and Ketchel, 1966) . During diapause, embryos or organisms undergo a reversible biosynthetic/metabolic dormancy, in which certain cells must retain their properties of pluri-/multipotency to ensure reactivation of development at later stages. The molecular mechanisms governing mouse embryonic diapause are largely unsolved and key factors regulating embryonic dormancy have yet to be identified (Hondo and Stewart, 2005) . In this study, we identify Myc as a master regulator of RNA processing, protein synthesis, and proliferation both in 2i-cultured ESCs and in the pre-implantation and Diapause/E4.5 epiblasts. Dataset is from Boroviak et al. (2015) . Red regions correspond to concordantly higher or lower expression. Blue and green regions correspond to lower or higher expression in one direction, but not in the other. Terms in yellow regions show anti-correlating behavior. Analysis was performed using the Perseus software according to Cox and Mann (2008) . FDR = 0.02. (B-E) Scatterplots of pathways significantly changed both in the comparison dKO/WT (FDR = 0.1) and in Diapause/E4.5 (FDR = 0.1). The gray dots represent the set of all genes. Genes belonging to the specific pathways are highlighted in blue (downregulated processes) or red (upregulated processes). The x axis shows the DESeq2-moderated log 2 fold change (log 2 fc) between the diapause compared to the E4.5 epiblast; the y axis shows the DESeq2-moderated log 2 fc between the dKO ESCs compared to c-myc embryo and propose the depletion of Myc activity as an important signal for the execution of the diapause program. Myc expression is indeed strongly reduced during the physiological and reversible state of embryonic dormancy, and cellular processes controlled by Myc in ESCs, such as RNA splicing, DNA and protein synthesis, and cellular proliferation, are dramatically affected during diapause. The observation that transient inhibition of Myc activity in pre-implantation blastocysts is on its own sufficient to trigger a diapause-like state of biosynthetic suspension without affecting pluripotent identity or compromising the developmental program is remarkable. Upon release of Myc inhibition, ground-state ESC re-enter into the cell cycle and diapause-like embryos progress through their normal developmental program. Yet, finely tunable genetic gain-of-function models will be needed to assess whether sustained Myc expression would prevent entry into diapause and provide additional evidence that Myc activity is sufficient to exit from the dormant state in vivo. Biosynthetic and energetic demands are intimately coupled. Diapaused embryos are characterized by a robust downregulation of biosynthetic processes, which is likely associated with a reduced bioenergetic activity. Metabolomics studies will need to explore whether the type or only the extent of energy production is different in normal and diapause embryos and how Myc interferes with this process (Hsieh et al., 2015; Takubo et al., 2013) . In summary, our findings suggest pluripotent stem cell dormancy as a Myc low state and identify differential Myc activity as a key event in orchestrating the complex and rapid changes occurring during entry and exit from diapause. Successful implantation results from the reciprocal interaction between an implantation-competent blastocyst and the receptive uterus (Wang and Dey, 2006) . Among other factors, the estrogen-induced cytokine LIF, secreted first by the uterine glands and then by the surrounding stroma, is crucial for the preparation of the uterus for implantation. Females lacking a functional LIF gene are fertile, but their blastocysts fail to implant and can only continue embryogenesis if transferred to wild-type pseudo-pregnant recipients (Chen et al., 2000; Stewart et al., 1992) . Similarly, embryos lacking gp130, part of the LIF receptor complex, cannot resume development after undergoing diapause (Nichols et al., 2001) , confirming the essential role of LIF/Stat3 signaling within the diapause program. Although it has been suggested that c-Myc lies downstream of LIF/Stat3 in ESCs cultured in serum (Cartwright et al., 2005) , the connection between the two pathways remains controversial in ESCs and may depend on culture conditions (Hall et al., 2009; Martello et al., 2013) . To identify the mechanisms controlling Myc activity in normal and diapaused epiblasts within their natural uterine microenvironment, future studies will need to elucidate the complex signaling interactions between LIF/Stat3 and Myc downstream of estrogens.
At the cellular level, our findings may not be restricted to the embryo but also apply to dormant, somatic stem cells where the quiescent state is known to protect them from mutations that might occur following replicative stress and result in aging, stem cell loss, or in the transition toward a cancerous state (Cheung and Rando, 2013; Latil et al., 2012; Sosa et al., 2014; Wagner et al., 1993; Wilson et al., 2008 Wilson et al., , 2009 ). In the hematopoietic system, for instance, the exit of HSCs from (E and F) MYCi-treated and control blastocysts were transplanted into the uteri of pseudo-pregnant foster mothers. (E) Representative images of E15.5 embryos derived from MYCi-treated or control blastocysts. This result is representative of two independent experiments. MYCi (n = 24 embryos E15.5); control (n = 11 embryos E15.5). Scale bar, 0.5 cm. (F) Representative picture of the litter generated from the transplant of MYCi-treated blastocysts into pseudo-pregnant foster mothers. The result is representative of two independent experiments. In the MYCi condition, totally nine litters were born from nine embryo-transferred foster mothers (totally 64 live-born mice).
dormancy triggered by interferon-a is associated to the upregulation of c-Myc protein (Ehninger et al., 2014) . Additionally, upon conditional deletion of both c-myc and N-myc in the bone marrow, the only maintained blood cells are dormant HSCs, while non-stem cells undergo rapid apoptosis . Dormancy is therefore a transient stem cell state, molecularly defined by extremely low levels of Myc expression, where the most primitive cells within the stem cell compartment can be stored as a transiently quiescent reservoir to preserve genomic integrity and be protected from microenvironmental hazards (Baldridge et al., 2010; Essers et al., 2009; Flach et al., 2014; Walter et al., 2015; Wilson et al., 2008) . This phenomenon might not be exclusive to normal stem cells but similarly be exploited in cancer, for example, by malignant metastatic stem cells following invasion into a new tissue environment (Oskarsson et al., 2014; Sosa et al., 2014) . In tumor cells with stemlike character, environmentally mediated physiological downregulation or pharmacological inhibition of Myc may thus induce tumor cell dormancy instead of apoptosis.
EXPERIMENTAL PROCEDURES
Other procedures and reagents details are provided in the Supplemental Experimental Procedures.
Mice Six-to 12-week-old mice were used throughout the study. C57BL/6 mice were purchased from Harlan Laboratories. Teratoma assays were performed in NOD.Cg-Prkdc (Knoepfler et al., 2002; Srinivas et al., 2001; Trumpp et al., 2001 ) and c-Myc eGFP/eGFP (Huang et al., 2008) mice were bred in-house in the animal facility of the DKFZ, Heidelberg, Germany. All mice were maintained at the DKFZ under specific pathogen-free (SPF) conditions in individually ventilated cages (IVCs). Animal procedures were performed according to protocols approved by the German authorities, Regierungsprä sidium Karlsruhe (Nr. Z110/02, DKFZ 299 and G135/15). (Knoepfler et al., 2002; Srinivas et al., 2001; Trumpp et al., 2001) or c-Myc eGFP/eGFP (Huang et al., 2008) mice. Females were injected intraperitoneally with 7U of pregnant mare serum gonadotropin (PMSG) followed by 7 U of human chorionic gonadotropin (hCG), injected 47 hr later. Females were then paired with males and checked for vaginal plug the following morning, considered as 0.5 days post-coitum (dpc). 2.5-dpc embryos were flushed from the oviducts into a plastic dish with M2 medium (Sigma, M7167). Embryos were washed ten times in M2 medium. To remove the zona pellucida, embryos were incubated shortly in Tyrode's solution (Sigma, T1788-100ML) and transferred again to M2 medium. Finally, each embryo was cultured on a layer of mitotically inactivated mouse embryonic fibroblasts (MEFs). ESCs were routinely propagated on 0.1% gelatin-coated plates, without feeders or serum, in N2B27 medium (NDiff N2B27 base medium, Stem Cell Sciences, SCS-SF-NB-02) supplemented with the small-molecule inhibitors PD0325901 (Stemgent, 04-0006, 1 mM) and CHIR99021 (Stemgent, 04-0004, 3 mM), LIF (Millipore, ESG1106, 1,000 U/ml), and b-mercaptoethanol (Gibco, 31350-010, 0.05 mM). Cells were replated every 3 days following dissociation with StemPro Accutase (Gibco, A11105-01). In the experiments with serum, ESCs were cultured on MEFs in knockout DMEM medium (Gibco, 10829) supplemented with L-glutamine (Gibco, 25030-081, 2 mM), LIF (Millipore, ESG1106, 1,000 U/ml), b-mercaptoethanol (Gibco, 31350-010, 0.05 mM), and 15% ESC-tested FBS (Pansera ES, Pan Biotech, 2602-P271303). In the experiments with the small-molecule inhibitor 10058-F4 (MYCi) (Calbiochem, 475956), MYCi was dissolved in 2i medium at a final concentration of 64 mM. As a control, DMSO alone was added at the same final volume as MYCi.
Embryonic Stem Cell Derivation and Culture
Induction of Diapause
Six-to 10-week-old female mice were injected intraperitoneally with 7 U of pregnant mare serum gonadotropin (PMSG) followed by 7 U of human chorionic gonadotropin (hCG), injected 48 hr later. The females were paired with males and checked for vaginal plug the following morning, considered as 0.5 days postcoitum (dpc). At 2.5 dpc, the females were ovariectomized, and diapause embryos were isolated by uterine flush 4 days later at 6.5 dpc. The control group was not operated and females were sacrificed at 3.5 or 4.5 dpc for embryo isolation.
Treatment of Mouse Blastocysts with the Myc Inhibitor 10058-F4 and Embryo Transfer E3.75-E4.0 embryos were collected from superovulated C57BL/6 pregnant females and incubated for 18 hr with the Myc inhibitor (MYCi) 10058-F4 (Calbiochem, 475956, final concentration 55 mM) in EmbryoMax KSOM medium + amino acids (Merck Millipore, MR121-D). The control group was treated with DMSO alone, added at the same final volume as the inhibitor. Treated embryos were transferred into the uterus of CD1 pseudo-pregnant foster mothers and analyzed at E15.5 or after birth.
Analysis of OP-Puro and EdU Incorporation Using the Click-iT Technology
To measure protein synthesis, in-vitro-cultured ESCs or mouse embryos were incubated for 1 hr in 2i medium or EmbryoMax KSOM medium + amino acids (Merck Millipore, MR121-D), respectively, supplemented with O-propargylpuromycin (OP-Puro) (Jena Biosciences, NU-931-05, 50 mM final concentration). After harvesting, the samples were fixed for 15 min at room temperature in PBS supplemented with 4% paraformaldehyde (Electron Microscopy Sciences, 19208) and then permeabilized in PBS supplemented with 1% BSA and 0.1% saponin for 5 min at room temperature. The copper-catalyzed azide-alkyne cycloaddition (CuAAC) was performed using an Alexa 647-azide (Life Technologies, A10277, 5 mM final concentration) and the Click-iT Cell Reaction Buffer Kit (Life Technologies, C10269) according to the manufacturer's instructions. For the analysis of EdU incorporation, isolated embryos were incubated in EmbryoMax KSOM medium + amino acids (Merck Millipore, MR121-D) supplemented with EdU (10 mM final concentration) for 80 min. EdU labeling and staining of the embryos were performed using the Click-iT Plus EdU Alexa Fluor 647 Flow Cytometry Assay Kit (Life Technologies, C10634) according to the manufacturer's instructions.
Statistical Analysis
Data were processed using Prism 6 (GraphPad Software). All analyses were performed using two-tailed Student's t tests (unless otherwise specified). Statistical significance is indicated by *p < 0.05; **p < 0.01; ***p < 0.001; and ****p < 0.0001.
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